Index RUT
P/E -
EPS (ttm) -0.89
Insider Own 3.21%
Shs Outstand 78.62M
Perf Week 0.27%
Market Cap 871.11M
Forward P/E 11.85
EPS next Y 0.93
Insider Trans -0.00%
Shs Float 76.10M
Perf Month -0.09%
Income -66.20M
PEG -
EPS next Q 0.21
Inst Own 66.47%
Short Float 8.93%
Perf Quarter 10.14%
Sales 2.06B
P/S 0.42
EPS this Y -12.89%
Inst Trans -3.13%
Short Ratio 6.94
Perf Half Y 33.82%
Book/sh 10.63
P/B 1.04
EPS next Y 8.38%
ROA -1.81%
Short Interest 6.80M
Perf Year -32.40%
Cash/sh 0.52
P/C 21.20
EPS next 5Y 1.20%
ROE -7.77%
52W Range 7.20 - 16.68
Perf YTD 5.52%
Dividend Est. 0.76 (6.86% )
P/FCF 3.92
EPS past 5Y -
ROI -2.27%
52W High -33.57%
Beta 0.67
Dividend TTM 0.76 (6.86% )
Quick Ratio 0.89
Sales past 5Y 4.23%
Gross Margin 21.22%
52W Low 53.89%
ATR (14) 0.29
Dividend Ex-Date Mar 27, 2024
Current Ratio 3.06
EPS Y/Y TTM -515.22%
Oper. Margin 11.86%
RSI (14) 53.91
Volatility 2.40% 2.34%
Employees 2912
Debt/Eq 2.53
Sales Y/Y TTM -4.65%
Profit Margin -3.21%
Recom 3.86
Target Price 10.14
Option/Short Yes / Yes
LT Debt/Eq 2.49
EPS Q/Q -90.28%
Payout -
Rel Volume 0.79
Prev Close 11.10
Sales Surprise 1.49%
EPS Surprise 5.30%
Sales Q/Q -7.24%
Earnings May 08 AMC
Avg Volume 980.14K
Price 11.08
SMA20 1.54%
SMA50 1.86%
SMA200 4.46%
Trades
Volume 776,394
Change -0.18%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-04-23 Downgrade
Piper Sandler
Neutral → Underweight
$14 → $8
Sep-13-23 Initiated
TD Cowen
Underperform
$10
Dec-01-22 Downgrade
Consumer Edge Research
Equal Weight → Underweight
$9
Jun-14-22 Upgrade
Piper Sandler
Underweight → Neutral
$25 → $23
Nov-05-21 Downgrade
Piper Sandler
Neutral → Underweight
$27
Mar-22-21 Downgrade
Piper Sandler
Overweight → Neutral
$31
Jan-20-21 Initiated
Stephens
Equal-Weight
$27
Jan-05-21 Downgrade
Credit Suisse
Neutral → Underperform
$28 → $25
Jul-28-20 Initiated
Seaport Global Securities
Neutral
Jun-12-20 Initiated
DA Davidson
Neutral
Jun-11-20 Initiated
RBC Capital Mkts
Sector Perform
May-13-20 Upgrade
Piper Sandler
Neutral → Overweight
$21 → $28
Apr-28-20 Upgrade
Credit Suisse
Underperform → Neutral
$17 → $19
Jan-23-20 Initiated
Jefferies
Hold
Jan-22-20 Initiated
Jefferies
Hold
Jun-12-19 Initiated
Evercore ISI
In-line
Feb-27-19 Downgrade
Buckingham Research
Buy → Neutral
$36 → $23
Dec-12-18 Initiated
CL King
Buy
Jun-19-18 Resumed
Piper Jaffray
Neutral
$31
Mar-07-18 Downgrade
Credit Suisse
Neutral → Underperform
Show Previous Ratings
Apr-24-24 08:00AM
Apr-17-24 05:15PM
Apr-15-24 11:11AM
03:58AM
Apr-11-24 09:40AM
11:30AM
Loading…
Mar-28-24 11:30AM
Mar-26-24 09:40AM
09:40AM
Mar-21-24 11:15AM
Mar-02-24 08:05AM
Mar-01-24 07:23AM
Feb-28-24 12:13PM
06:40AM
(Thomson Reuters StreetEvents)
05:47AM
Feb-27-24 06:20PM
(Associated Press Finance)
04:46PM
Loading…
04:46PM
04:37PM
04:14PM
Feb-26-24 06:10PM
02:00AM
Feb-22-24 10:31AM
Feb-19-24 04:55PM
Feb-05-24 04:05PM
Feb-01-24 09:00AM
Jan-31-24 05:19PM
05:42AM
Jan-16-24 09:17AM
Jan-10-24 07:44AM
Jan-02-24 12:14PM
Dec-18-23 06:15AM
11:41AM
Loading…
Dec-08-23 11:41AM
11:30AM
Nov-13-23 06:30PM
Nov-09-23 05:31PM
08:54AM
05:52AM
Nov-08-23 06:28PM
05:28PM
(Associated Press Finance)
04:06PM
04:05PM
Nov-06-23 09:51AM
Nov-02-23 10:00AM
Nov-01-23 10:01AM
Oct-25-23 06:37PM
Oct-12-23 06:45AM
Oct-09-23 09:53AM
Oct-04-23 03:51PM
09:53AM
01:55AM
Sep-28-23 08:48AM
Sep-26-23 04:05PM
Sep-22-23 11:55AM
Sep-13-23 01:31PM
Sep-12-23 09:42PM
08:40AM
Sep-06-23 03:09AM
Sep-05-23 12:07PM
Aug-31-23 09:29AM
Aug-17-23 07:46AM
Aug-03-23 06:25PM
05:17PM
04:05PM
Aug-01-23 06:42PM
Jul-21-23 04:05PM
Jul-07-23 06:34AM
Jul-06-23 09:40AM
05:05AM
Jul-05-23 09:01AM
Jun-24-23 11:00AM
Jun-21-23 08:00PM
May-26-23 10:39AM
May-24-23 07:44AM
May-16-23 09:03PM
May-05-23 08:22AM
May-04-23 06:25PM
05:21PM
04:05PM
May-03-23 06:52PM
Apr-26-23 08:00PM
Apr-24-23 05:25PM
Apr-20-23 05:12AM
Apr-13-23 07:33AM
Apr-12-23 09:26AM
Apr-06-23 09:55AM
Apr-05-23 10:15AM
08:32AM
05:42AM
Mar-30-23 11:30AM
09:30AM
Mar-22-23 07:44PM
Mar-17-23 09:15AM
Mar-14-23 08:06AM
Mar-10-23 07:39AM
Mar-07-23 09:38AM
Mar-03-23 09:45AM
05:32AM
Mar-01-23 09:28AM
09:25AM
(Thomson Reuters StreetEvents)
Feb-28-23 07:25PM
04:05PM
B&G Foods, Inc. is a holding company, which engages in the manufacture, sale, and distribution of shelf-stable frozen food, and household products in the U.S., Canada, and Puerto Rico. Its products include frozen and canned vegetables, hot cereals, fruit spreads, canned meats and beans, bagel chips, spices, seasonings, hot sauces, and wine vinegar. Its brands include Back to Nature, Bear Creek, Cream of Wheat, Green Giant, Mrs. Dash, and Ortega. The company was founded in 1889 and is headquartered in Parsippany, NJ.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Greenberg Jordan E EVP & PRES OF SPICES & FLAVOR Jun 14 '23 Sale 13.45 13,000 174,882 56,999 Jun 14 06:21 PM
Index -
P/E 19.25
EPS (ttm) 2.49
Insider Own 12.77%
Shs Outstand 80.11M
Perf Week -2.68%
Market Cap 4.11B
Forward P/E -
EPS next Y -0.91
Insider Trans 0.00%
Shs Float 74.99M
Perf Month -9.12%
Income 242.57M
PEG -
EPS next Q -0.40
Inst Own 85.26%
Short Float 2.72%
Perf Quarter -4.70%
Sales 4.37B
P/S 0.94
EPS this Y -163.22%
Inst Trans -0.31%
Short Ratio 3.71
Perf Half Y 12.59%
Book/sh 70.75
P/B 0.68
EPS next Y 51.80%
ROA 2.34%
Short Interest 2.04M
Perf Year -10.31%
Cash/sh 16.92
P/C 2.83
EPS next 5Y -
ROE 4.04%
52W Range 41.39 - 69.85
Perf YTD -8.65%
Dividend Est. -
P/FCF 85.42
EPS past 5Y -14.72%
ROI 2.86%
52W High -31.50%
Beta 1.47
Dividend TTM -
Quick Ratio 2.36
Sales past 5Y 5.68%
Gross Margin 58.47%
52W Low 15.61%
ATR (14) 1.20
Dividend Ex-Date -
Current Ratio 2.36
EPS Y/Y TTM 119.56%
Oper. Margin -5.75%
RSI (14) 38.96
Volatility 2.12% 2.37%
Employees 9500
Debt/Eq 0.41
Sales Y/Y TTM -16.62%
Profit Margin 5.56%
Recom 1.23
Target Price 74.78
Option/Short Yes / Yes
LT Debt/Eq 0.39
EPS Q/Q 23225.00%
Payout 0.00%
Rel Volume 1.04
Prev Close 47.56
Sales Surprise -0.42%
EPS Surprise 2125.18%
Sales Q/Q -15.12%
Earnings May 07 AMC
Avg Volume 550.36K
Price 47.85
SMA20 -2.93%
SMA50 -7.71%
SMA200 -8.37%
Trades
Volume 597,569
Change 0.61%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-15-23 Upgrade
UBS
Sell → Neutral
$46 → $54
Dec-13-22 Initiated
Citigroup
Buy
$60
Dec-02-22 Initiated
UBS
Sell
$46
Jan-07-22 Resumed
Goldman
Buy
$173
Jan-03-22 Resumed
JP Morgan
Overweight
$185 → $175
Oct-07-21 Reiterated
The Benchmark Company
Buy
$200 → $218
Jul-21-21 Upgrade
BMO Capital Markets
Market Perform → Outperform
$250 → $170
May-27-21 Downgrade
BTIG Research
Buy → Neutral
Dec-23-20 Downgrade
BMO Capital Markets
Outperform → Market Perform
$165 → $175
Sep-25-20 Resumed
Piper Sandler
Overweight
$145
Sep-15-20 Initiated
KeyBanc Capital Markets
Overweight
$160
Aug-12-20 Reiterated
Wedbush
Outperform
$168 → $170
Jul-08-20 Initiated
Goldman
Neutral
$135
Jul-07-20 Resumed
JP Morgan
Overweight
$155
Jun-11-20 Initiated
BTIG Research
Buy
Dec-23-19 Initiated
Wedbush
Outperform
$295
Nov-08-19 Downgrade
JP Morgan
Overweight → Neutral
$300 → $245
Sep-17-19 Initiated
Citigroup
Buy
$290
Aug-09-19 Upgrade
Guggenheim
Neutral → Buy
$300
May-13-19 Downgrade
JMP Securities
Mkt Outperform → Mkt Perform
Show Previous Ratings
May-01-24 06:45PM
10:00AM
09:03AM
Apr-30-24 10:01AM
Apr-29-24 08:50AM
04:10PM
Loading…
Apr-16-24 04:10PM
04:10PM
Apr-15-24 09:30AM
Apr-11-24 09:00AM
Mar-05-24 09:00AM
Feb-24-24 03:26PM
Feb-23-24 11:35AM
Feb-16-24 03:12PM
Feb-15-24 11:24AM
09:36AM
08:00PM
Loading…
Feb-13-24 08:00PM
07:30PM
04:56PM
04:10PM
04:10PM
Feb-12-24 09:16AM
Feb-11-24 05:43PM
(The Wall Street Journal)
Feb-07-24 06:23AM
Jan-17-24 04:10PM
04:10PM
09:00AM
Jan-11-24 09:15AM
Jan-09-24 05:54AM
(The Wall Street Journal)
Dec-16-23 06:52AM
Dec-14-23 09:26AM
10:00AM
Loading…
Dec-11-23 10:00AM
Nov-29-23 04:10PM
Nov-27-23 04:26AM
Nov-21-23 12:22PM
Nov-16-23 10:00AM
Nov-09-23 04:10PM
03:14PM
02:17PM
09:10AM
Nov-08-23 04:24PM
Nov-07-23 04:10PM
04:10PM
Nov-06-23 05:27AM
Nov-05-23 01:25AM
Oct-26-23 10:41AM
Oct-18-23 04:10PM
04:10PM
Oct-16-23 10:00AM
02:41AM
Oct-10-23 09:59AM
Oct-05-23 01:30PM
06:25AM
Sep-27-23 10:00AM
Sep-14-23 09:07AM
Sep-08-23 05:32AM
Aug-30-23 04:10PM
Aug-11-23 11:41AM
Aug-09-23 04:47PM
12:49PM
Aug-08-23 04:10PM
04:10PM
Aug-02-23 10:07AM
Aug-01-23 09:03AM
Jul-19-23 04:10PM
10:15AM
Jul-13-23 01:19PM
02:17AM
Jul-12-23 08:59AM
Jul-06-23 06:31AM
Jul-05-23 04:53AM
Jun-28-23 04:24PM
(The Wall Street Journal)
Jun-20-23 04:05PM
Jun-16-23 01:53PM
(The Wall Street Journal)
09:10AM
Jun-13-23 09:00AM
Jun-08-23 11:02AM
May-24-23 04:10PM
May-19-23 10:01AM
(The Wall Street Journal)
May-16-23 10:08AM
May-15-23 04:10PM
May-10-23 03:19PM
(Morningstar Research) +11.92%
01:50PM
May-09-23 04:10PM
09:06AM
May-06-23 09:47AM
Apr-12-23 04:10PM
Apr-11-23 05:54PM
Apr-04-23 10:20AM
Apr-03-23 09:24AM
Mar-31-23 08:11AM
Mar-28-23 01:27PM
Mar-16-23 10:12AM
Mar-09-23 10:00AM
Mar-08-23 05:42AM
Mar-06-23 09:13AM
09:03AM
Feb-28-23 09:03AM
Feb-26-23 07:30AM
Feb-23-23 07:00AM
Feb-21-23 04:10PM
IAC, Inc. engages in media and Internet business. It operates through the following segments: Dotdash Meredith, Angi Inc, Search, and Emerging and Other. The Dotdash Meredith segment provides digital and print publishing services from mobile to magazines. The ANGI Homeservices segment offers repairing, remodeling, cleaning, and landscaping through category-transforming products under HomeAdvisor, Angie's List, Handy, and Fixd Repair brands. The Search segment consists of Ask Media Group, which provides general search services and information. The Emerging and Other segment includes platforms Care.com, Bluecrew, NurseFly Mosaic Group, Vivian Health, The Daily Beast, IAC Films, and Newco. The company was founded on August 24, 1995, and is headquartered in New York, NY.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
LEVIN JOSEPH CEO Feb 23 '24 Option Exercise 13.48 100,000 1,348,000 3,387,614 Feb 27 04:30 PM Handler Kendall EVP & CHIEF LEGAL OFFICER Feb 08 '24 Option Exercise 0.00 11,768 0 19,804 Feb 12 08:30 PM Halpin Christopher EVP, CFO & COO Feb 08 '24 Option Exercise 0.00 56,486 0 67,826 Feb 12 08:30 PM EISNER MICHAEL D Director Jun 25 '23 Option Exercise 0.00 1,347 0 160,538 Jun 27 04:15 PM Lourd Bryan Director Jun 25 '23 Option Exercise 0.00 1,347 0 159,634 Jun 27 04:15 PM Hammer Bonnie S Director Jun 25 '23 Option Exercise 0.00 1,347 0 26,870 Jun 27 04:15 PM SPOON ALAN G Director Jun 25 '23 Option Exercise 0.00 1,347 0 234,578 Jun 27 04:15 PM ZANNINO RICHARD F Director Jun 25 '23 Option Exercise 0.00 1,347 0 50,636 Jun 27 04:15 PM ROSENBLATT DAVID S Director Jun 25 '23 Option Exercise 0.00 1,347 0 77,905 Jun 27 04:15 PM Von Furstenberg Alexander Director Jun 25 '23 Option Exercise 0.00 1,347 0 95,859 Jun 27 04:15 PM Clinton Chelsea Director Jun 25 '23 Option Exercise 0.00 1,347 0 71,625 Jun 27 04:15 PM Clinton Chelsea Director Jun 23 '23 Option Exercise 0.00 1,034 0 70,278 Jun 27 04:15 PM Von Furstenberg Alexander Director Jun 23 '23 Option Exercise 0.00 1,034 0 94,512 Jun 27 04:15 PM ROSENBLATT DAVID S Director Jun 23 '23 Option Exercise 0.00 1,034 0 76,558 Jun 27 04:15 PM ZANNINO RICHARD F Director Jun 23 '23 Option Exercise 0.00 1,034 0 49,289 Jun 27 04:15 PM SPOON ALAN G Director Jun 23 '23 Option Exercise 0.00 1,034 0 233,231 Jun 27 04:15 PM Hammer Bonnie S Director Jun 23 '23 Option Exercise 0.00 1,034 0 25,523 Jun 27 04:15 PM Lourd Bryan Director Jun 23 '23 Option Exercise 0.00 1,034 0 158,287 Jun 27 04:15 PM EISNER MICHAEL D Director Jun 23 '23 Option Exercise 0.00 1,034 0 159,191 Jun 27 04:15 PM SPOON ALAN G Director May 14 '23 Option Exercise 0.00 549 0 232,197 May 16 04:33 PM ROSENBLATT DAVID S Director May 14 '23 Option Exercise 0.00 549 0 75,524 May 16 04:32 PM ZANNINO RICHARD F Director May 14 '23 Option Exercise 0.00 549 0 48,255 May 16 04:34 PM Von Furstenberg Alexander Director May 14 '23 Option Exercise 0.00 549 0 93,478 May 16 04:34 PM Lourd Bryan Director May 14 '23 Option Exercise 0.00 549 0 157,253 May 16 04:24 PM Clinton Chelsea Director May 14 '23 Option Exercise 0.00 549 0 69,244 May 16 04:22 PM Hammer Bonnie S Director May 14 '23 Option Exercise 0.00 549 0 24,489 May 16 04:20 PM EISNER MICHAEL D Director May 14 '23 Option Exercise 0.00 549 0 158,157 May 16 04:22 PM
Index -
P/E 13.23
EPS (ttm) 7.37
Insider Own 0.00%
Shs Outstand 2.04B
Perf Week -0.86%
Market Cap 190.76B
Forward P/E 12.38
EPS next Y 7.87
Insider Trans -
Shs Float 1.96B
Perf Month 3.27%
Income 15.24B
PEG 1.42
EPS next Q 1.82
Inst Own 7.27%
Short Float 0.19%
Perf Quarter -5.77%
Sales 48.66B
P/S 3.92
EPS this Y 11.43%
Inst Trans -9.05%
Short Ratio 2.36
Perf Half Y 3.99%
Book/sh 19.44
P/B 5.01
EPS next Y 9.21%
ROA 8.86%
Short Interest 3.81M
Perf Year 0.48%
Cash/sh 4.98
P/C 19.56
EPS next 5Y 9.35%
ROE 19.96%
52W Range 88.86 - 108.78
Perf YTD -3.44%
Dividend Est. 3.68 (3.78%)
P/FCF 15.00
EPS past 5Y 5.63%
ROI 26.11%
52W High -10.37%
Beta 0.57
Dividend TTM 3.74 (3.84%)
Quick Ratio 0.71
Sales past 5Y 0.78%
Gross Margin 72.13%
52W Low 9.72%
ATR (14) 1.42
Dividend Ex-Date Mar 07, 2024
Current Ratio 0.90
EPS Y/Y TTM 126.83%
Oper. Margin 27.40%
RSI (14) 54.70
Volatility 1.00% 1.11%
Employees 76057
Debt/Eq 0.69
Sales Y/Y TTM -4.53%
Profit Margin 31.33%
Recom 2.56
Target Price 110.69
Option/Short Yes / Yes
LT Debt/Eq 0.47
EPS Q/Q 20.88%
Payout 44.73%
Rel Volume 0.69
Prev Close 97.13
Sales Surprise 3.40%
EPS Surprise 7.29%
Sales Q/Q -8.68%
Earnings Apr 23 BMO
Avg Volume 1.61M
Price 97.50
SMA20 2.11%
SMA50 -0.32%
SMA200 -0.73%
Trades
Volume 1,284,177
Change 0.38%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-23-24 Initiated
BMO Capital Markets
Market Perform
$114
Jan-23-24 Initiated
Morgan Stanley
Equal-Weight
$114
Jan-16-24 Resumed
UBS
Buy
Dec-18-23 Downgrade
HSBC Securities
Buy → Hold
Sep-25-23 Upgrade
Morgan Stanley
Underweight → Equal-Weight
Jul-14-23 Initiated
HSBC Securities
Buy
Apr-26-23 Upgrade
Deutsche Bank
Hold → Buy
Mar-27-23 Upgrade
Deutsche Bank
Sell → Hold
Jan-26-23 Downgrade
Citigroup
Buy → Neutral
Dec-05-22 Upgrade
Stifel
Hold → Buy
Sep-15-22 Downgrade
Credit Suisse
Neutral → Underperform
Sep-14-22 Downgrade
Berenberg
Buy → Hold
May-09-22 Downgrade
Wolfe Research
Outperform → Peer Perform
Jan-10-22 Resumed
Citigroup
Buy
Dec-14-21 Downgrade
Redburn
Buy → Neutral
Dec-06-21 Downgrade
Exane BNP Paribas
Outperform → Neutral
Dec-03-21 Downgrade
Bryan Garnier
Buy → Neutral
Sep-20-21 Downgrade
Deutsche Bank
Hold → Sell
Mar-22-21 Initiated
Bernstein
Mkt Perform
Mar-10-21 Downgrade
Argus
Buy → Hold
Show Previous Ratings
Today 03:01AM
(Pharmaceutical Technology)
May-01-24 01:46PM
01:46PM
11:12AM
10:00AM
11:50AM
Loading…
Apr-30-24 11:50AM
07:00AM
04:14AM
Apr-25-24 08:30AM
(Investor's Business Daily)
Apr-24-24 11:42AM
(Pharmaceutical Technology)
10:54AM
10:30AM
Apr-23-24 06:25PM
05:05PM
04:01PM
(Investor's Business Daily)
03:18PM
Loading…
03:18PM
02:38PM
01:54PM
01:42PM
12:53PM
12:34PM
(The Wall Street Journal)
12:24PM
12:16PM
12:15PM
12:07PM
(Associated Press Finance)
11:32AM
(The Wall Street Journal)
11:15AM
10:51AM
09:30AM
09:00AM
08:59AM
Loading…
08:59AM
(The Wall Street Journal)
08:52AM
(Investor's Business Daily)
07:45AM
07:29AM
(The Wall Street Journal)
05:15AM
(The Wall Street Journal)
05:02AM
(Associated Press Finance)
04:58AM
04:31AM
04:08AM
(The Wall Street Journal)
03:01AM
01:18AM
01:00AM
Apr-22-24 06:08PM
Apr-19-24 10:10AM
Apr-18-24 06:33PM
09:15AM
Apr-17-24 09:30AM
01:15AM
Apr-16-24 09:06AM
Apr-15-24 02:00PM
04:46AM
Apr-12-24 01:55PM
08:53AM
(Pharmaceutical Business Review)
06:26AM
Apr-11-24 04:19PM
(Investor's Business Daily)
11:27AM
09:45AM
09:17AM
(Investor's Business Daily)
08:06AM
07:40AM
07:17AM
07:00AM
04:39AM
04:20AM
Apr-10-24 10:12AM
08:11AM
08:11AM
Apr-09-24 10:15AM
Apr-06-24 04:16PM
Apr-05-24 06:00PM
Apr-04-24 03:42PM
Apr-03-24 08:48AM
Apr-02-24 06:15PM
11:22AM
Apr-01-24 04:56PM
Mar-31-24 04:34PM
Mar-30-24 03:52PM
Mar-29-24 05:02PM
Mar-28-24 09:00AM
Mar-27-24 06:00PM
Mar-26-24 01:06PM
07:49AM
06:18AM
Mar-25-24 06:15PM
12:58PM
07:26AM
(Pharmaceutical Business Review)
Mar-24-24 10:40AM
08:15AM
Mar-22-24 07:22AM
Mar-19-24 06:00PM
Mar-18-24 06:15PM
01:28PM
Mar-17-24 08:50AM
Mar-15-24 10:37AM
Mar-14-24 09:38AM
09:00AM
08:45AM
Mar-13-24 09:02AM
07:08AM
Mar-12-24 06:00PM
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite